Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cancer Stem Cells: Are We Missing the Target?

20 Apr 2004

Abstract excerpt

Most conventional anticancer agents are nonselective cellular poisons with broad activities against most dividing cells, regardless of whether they are malignant or not; any preferential effects of these agents on cancer cells usually reflect their relatively high rates of cell division. The widely acclaimed success of imatinib mesylate (also known as STI571 or Gleevec, and herein referred to as imatinib) in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer-related Molecular Pathways
Share to Chronic Myeloid Leukemia Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15100335
DOI: 10.1093/jnci/djh095

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer Stem Cells: Are We Missing the Target?PMID 15100335Read ↗

The chronic myeloid leukemia stem cell: stemming the tide of persistenceSemantic proximity Read ↗

Targeting Leukemic Stem Cells in Chronic Myeloid Leukemia: Is It Worth the Effort?Semantic proximity Read ↗

Chronic myeloid leukemia stem cells: targeting therapeutic implicationsSemantic proximity Read ↗

Critical molecular pathways in cancer stem cells of chronic myeloid leukemia.Semantic proximity Read ↗

Chronic Myeloid Leukemia Stem CellsSemantic proximity Read ↗

Stem cells: The cancer's gone, but did chemotherapy damage your heart?Semantic proximity Read ↗

The CML stem cell: Evolution of the progenitorSemantic proximity Read ↗

Emerging stem cell concepts for imatinib-resistant chronic myeloid leukaemia: implications for the biology, management, and therapy of the disease.Semantic proximity Read ↗

Insights into the stem cells of chronic myeloid leukemia.Semantic proximity Read ↗

Chronic Myeloid Leukemia Stem CellsSemantic proximity Read ↗

Why do chronic myelogenous leukemia stem cells survive allogeneic stem cell transplantation or imatinib: does it really matter?Semantic proximity Read ↗

BCR-ABL kinase is dead; long live the CML stem cellSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.